Market Research Report
Targeted Oncology Therapeutics
|Published by||Greystone Research Associates||Product code||925944|
Delivery time: 1-2 business days
|Targeted Oncology Therapeutics|
|Published: February 16, 2020||Content info:||
A number of factors are changing the way market participants view the cancer therapeutics market. These factors are evident in the disease targets and drug classes that comprise a significant number of recent trials. After decades of disappointment and missed financial objectives, the genetic underpinnings of disease are converging with improved computer-assisted pharmacological decision making. Market sector participants now find themselves pursuing realistic therapeutic strategies that have the potential to fulfill product strategies in both scientific and human terms.